The new promising technology for lymphoma and leukemia patients
using the cutting edge technology of CAR-T-Cells, empowering the immune system to fight against the tumor, is available now for the first time outside the USA, at the Tel-Aviv Medical Center (Ichilov Hospital).
The CAR-T-CELLS treatment relies on the most advanced technology, which recruits the immune system to fight against the tumor: a small number of the patient’s own immune system cells are collected from his blood, undergo genetic engineering abroad by commercial companies approved by the European, American, and Israeli authorities to perform this process, and then are infused into the patient in a single treatment with the objective of destroying the cancer cells. The Tel-Aviv Medical Center is the first center outside of the United States that has been providing this treatment since February 2016.
